Digital Health & Technology

  • March 16, 2026

    Medtronic Seeks To Ax 'Extreme Outlier' $382M Antitrust Loss

    Medtronic has urged a California federal judge to scrap its nearly $382 million trial loss to rival Applied Medical over Medtronic's bundling practices that a jury found suppressed competition for advanced bipolar devices, arguing the verdict is an "extreme outlier" in antitrust law that can't survive.

  • March 11, 2026

    DNA Testing Co. Can't Shake Suit Over Genetic Data Sharing

    A Massachusetts federal judge refused to release Nebula Genomics Inc. from a proposed class action accusing it of illegally sharing its customers' genetic information with Meta and other third parties through online tracking tools, finding that the parties' choice-of-law agreement didn't extend to the plaintiff's genetic privacy allegation. 

  • March 10, 2026

    UnitedHealth Must Reveal Nitty-Gritty In Claim Denial AI Case

    A Minnesota federal judge has ordered UnitedHealth Group to hand over discovery on the secretive algorithm it uses to manage Medicare Advantage claims, ruling Monday that the insurer must disclose internal records detailing whether the technology was designed to override the clinical judgment of doctors.

  • March 09, 2026

    Fla. Judge Finds Leapfrog's Hospital Ratings Deceptive, Unfair

    A Florida federal judge ordered hospital ratings nonprofit Leapfrog to revoke poor safety grades it issued to five hospitals owned by Tenet Healthcare Corp., finding the group's approach to evaluating the hospitals and publicizing its findings was unfair and deceptive.

  • March 09, 2026

    Abortion Rights Group, SD Agree to End Gas Station Ads Row

    An abortion rights group can no longer post advertisements at gas stations in South Dakota that promote abortion care, the South Dakota attorney general's office announced on Monday, saying that the group and the state have reached an agreement in a pair of lawsuits over the advertising campaign. 

  • March 09, 2026

    Novo, Hims & Hers Make Up, Agree To Sell GLP-1s Together

    Novo Nordisk A/S will start selling its GLP-1 medications on Hims & Hers Health Inc.'s platform as part of a deal that resolves the pharmaceutical company's patent infringement lawsuit against the telehealth provider, the companies announced Monday.

  • March 09, 2026

    NC Providers Sue UnitedHealth Over 'Devastating' Cyberattack

    UnitedHealth Group Inc. and several of its subsidiaries are facing a proposed class action in North Carolina state court over a 2024 data breach that took its claims processing platform offline and allegedly delayed billions of dollars in reimbursements to providers.

  • March 06, 2026

    TriZetto, Cognizant Hit With Class Claims Over Data Breach

    A Cognizant Technology Solutions-owned healthcare tech company was hit with a proposed class action in New Jersey federal court on Friday over its alleged failure to protect the sensitive personal and health information of thousands.

  • March 04, 2026

    Care Management Co. Accused Of Swiping Software Platform

    The developer of software used in the Medicare treatment arena has sued a customer care management company in Delaware Chancery Court, accusing it of wrongfully using the platform to create a competing application.

  • March 04, 2026

    9th Circ. Hesitant To Revive Implant Suit Against Medtronic

    A Ninth Circuit panel cast doubt Wednesday on a Washington man's attempt to revive a negligence lawsuit against Medtronic for allegedly not assisting him when his spinal implant malfunctioned, hinting that his failure to find an expert witness to testify the device caused his pain may be fatal to the case.

  • March 03, 2026

    FDA Targets Advertising For Knockoff Weight-Loss Meds

    The U.S. Food and Drug Administration on Tuesday accused about 30 telehealth companies of illegally marketing compounded weight-loss and diabetes drugs, the agency's latest salvo in a crackdown on direct-to-consumer pharmaceutical advertising.

  • March 03, 2026

    FDA Rare-Disease Guidance Brings Both Hope And Questions

    Federal regulators want to speed rare disease treatment development. It isn’t clear who will — and won’t — be allowed to take advantage of the program.

  • February 27, 2026

    AI-Focused Generate Biomedicines Prices $400M IPO

    The CEO of Generate Biomedicines, a biotechnology firm using artificial intelligence to develop therapies for immunology and oncology, on Friday rang the Nasdaq opening bell as the company expects to raise $400 million for its initial public offering.

  • February 26, 2026

    Kochava, FTC Near Deal To End Geolocation Privacy Suit

    The Federal Trade Commission and Kochava Inc. told an Idaho federal judge Thursday that they have negotiated a final deal to resolve claims alleging the mobile app analytics provider illegally sold geolocation data from mobile devices that could be used to track people to reproductive health clinics, places of worship and other sensitive places.

  • February 25, 2026

    Centene Says Filed Rate Doctrine Dooms RICO, Fraud Claims

    Centene Corp. urged an Illinois federal judge Tuesday to grant it partial judgment in a proposed class action by patients alleging the company violated racketeering laws and cheated them out of billions with bogus policies, arguing the filed rate doctrine bars the refunds they seek for alleged overcharges.

  • February 24, 2026

    Abortion Pill Access, Tariff Questions And More In Court

    Law360 Healthcare Authority looks at drugmakers' intervention in federal litigation concerning mail-order abortion medication, questions left open by the U.S. Supreme Court's decision striking down tariffs and other significant litigation developments this week.

  • February 18, 2026

    Meta Pixel Tracking Suit Tossed Over Lack Of Standing

    A North Carolina federal judge has ruled that a prospective class of Nurse.com users lacked standing to sue the website's operator for Video Privacy Protection Act violations for allegedly sharing customers' information with Meta Platforms Inc. without permission.

  • February 18, 2026

    Neutrogena Paying $4.7M To Settle BIPA Suit Over App

    A former Johnson & Johnson subsidiary has agreed to pay $4.7 million to settle a potential class action claiming it unlawfully stored and collected facial scans of people who used its Neutrogena Skin360 tool, according to a filing in New Jersey federal court.

  • February 18, 2026

    Pa. Providers Say They Lost Billions In Change Health Breach

    The health payment platform Change Health Inc., which was at the center of the nation's largest healthcare data breach two years ago, is facing a fresh lawsuit from a proposed class of Pennsylvania healthcare providers who claim they lost billions in payments during the breach. 

  • February 11, 2026

    'The Shoe Is On The Other Foot': Judge Needles Meta In MDL

    A California federal judge presiding over social media addiction multidistrict litigation Wednesday criticized Meta's bid to push newly filed arbitration demands into court, saying she doesn't have jurisdiction over those claims and noting "big companies" are always insisting on arbitration, but "when they don't like the fact that they're arbitrating, they complain about it."

  • February 11, 2026

    NY Judge Rejects Bid To Stop SD Action Against Abortion Ads

    A New York federal judge said Wednesday that she can't block South Dakota officials from pursuing state legal action against an abortion rights group that launched an advertising campaign in South Dakota, saying she doesn't have jurisdiction to halt the proceedings.

  • February 10, 2026

    Pa. Health Network Escapes Wiretapping Suit, For Now

    A Pennsylvania federal judge has tossed class claims alleging Penn Highlands Healthcare Inc. violated state wiretapping laws by sharing patient health information with Google Analytics, reasoning that the patients suing the healthcare network need to provide more specifics about the harm they alleged.

  • February 10, 2026

    Meet The Attys For Novo Nordisk In Hims & Hers GLP-1 Row

    Rodger D. Smith II and Jeremy A. Tigan of Morris Nichols Arsht & Tunnell LLP represent Novo Nordisk in its challenge against telehealth company Hims & Hers Health Inc.

  • February 10, 2026

    Apple Again Pushes To Escape Masimo's $634M IP Verdict

    Apple is doubling down on its bid to have U.S. District Judge James V. Selna relieve it from a jury's $634 million infringement verdict in litigation over its Apple Watch, saying Masimo Corp. relied on an improper and "shifting" definition of a dispositive term.

  • February 10, 2026

    Novo Nordisk Takes On Hims Over Copycat GLP-1 Pill

    Novo Nordisk's patent infringement suit against telehealth company Hims & Hers over an affordable GLP-1 pill is an escalation in the larger battle between obesity drugmakers and compounding pharmacies.

Expert Analysis

  • Previewing State Efforts To Regulate Mental Health Chatbots

    Author Photo

    New York, Nevada and Utah have all recently enacted laws regulating the use of artificial intelligence to deliver mental health services, offering early insights into how other states may regulate this area, say attorneys at Goodwin.

  • How DOJ's New Data Security Rules Leave HIPAA In The Dust

    Author Photo

    The U.S. Department of Justice's recently effective data security requirements carry profound implications for how healthcare providers collect, store, share and use data — and approach vendor oversight — that go far beyond the Health Insurance Portability and Accountability Act, say attorneys at Nelson Mullins.

  • How The Healthline Privacy Settlement Redefines Ad Tech Use

    Author Photo

    The Healthline settlement is the first time California has drawn a clear line in the sand around how website tracking must function in practice, so if your site uses tracking technologies, especially around sensitive content like health or finance, regulators are inspecting your website's back end, not just its banner, say attorneys at Baker Donelson.

  • High Court Cert Spotlights Varying Tests For Federal Removal

    Author Photo

    A recent decision by the U.S. Supreme Court to review Chevron v. Plaquemines Parish, a case involving the federal officer removal statute, highlights three other recent circuit court decisions raising federal removal questions, and serves as a reminder that defendants are the masters of removal actions, says Varun Aery at Hollingsworth.

  • IRhythm IPR Denial Raises Key PTAB Discretion Questions

    Author Photo

    By giving the passage of time a dispositive role in denying institution of five inter partes review petitions filed by iRhythm Technologies, the U.S. Patent and Trademark Office has upended the strategic considerations for filing and defending against IPRs, disclosing prior art during prosecution, and engaging in licensing negotiations, say attorneys at Dentons.

  • Rising Enforcement Stakes For Pharma Telehealth Platforms

    Author Photo

    Two pieces of legislation recently introduced in Congress could transform the structure and promotion of telehealth arrangements as legislators increasingly scrutinize direct-to-consumer advertising platforms, potentially paving the way for a new U.S. Food and Drug Administration policy with bipartisan support, say attorneys at Sheppard Mullin.

  • Handling Revenue Cycle Management Disputes In The AI Age

    Author Photo

    As healthcare providers and revenue cycle management vendors face an increasing use of artificial intelligence in claims adjudication, it's important for providers and their general counsel to plan in advance for potential disagreements with vendors and investigate the root causes behind any underperformance that arises, say consultants at AlixPartners.

  • Prepare For Increased FDA Inspections Of Foreign Facilities

    Author Photo

    In light of the U.S. Food and Drug Administration's recently announced plans to expand use of unannounced inspections of foreign drug manufacturing factories, foreign firms should implement best practices in anticipation of an imminent increase in enforcement activity, say attorneys at McGuireWoods.

  • How Medical Practices Can Improve Privacy Compliance

    Author Photo

    In light of recent high-profile patient privacy violations, health practices — especially in California — should better position themselves to comply with medical privacy laws by shoring up strategies ranging from mapping electronic protected health information to building a better compliance culture, says Suzanne Natbony at Aliant Law.

  • 5 Open Questions About FDA's AI-Assisted Review Plans

    Author Photo

    The U.S. Food and Drug Administration recently touted the completion of a generative artificial intelligence program for scientific reviewers and plans for agencywide deployment to speed up reviews of premarket applications, but there is considerable uncertainty surrounding the tools' ability to protect trade secrets, avoid bias and more, say attorneys at King & Spalding.

  • 3 Takeaways From Recent Cyberattacks On Healthcare Cos.

    Author Photo

    For the healthcare industry, the upward trend in styles of cyberattacks, costs, and entities targeted highlights the critical importance of proactive planning to help withstand the operational, legal and reputational turmoil that can follow a data breach, say attorneys at Troutman Pepper.

  • How Focus On Menopause Care Is Fueling Innovation, Access

    Author Photo

    Recent legislative developments concerning the growing field of menopause care are creating opportunities for increased investment and innovation in the space as they increase access to education and coverage, say attorneys at Kirkland.

  • International Ramifications Of Canada's Health AI Moves

    Author Photo

    Recent artificial intelligence developments in Canada's health industry are creating ripple effects for global investors, cross-border innovators and legal practitioners, and may create opportunities for U.S. companies rethinking their international strategies, says Atoussa Mahmoudpour at AMR Law.